RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention
Recruiting
N/A
Interventional Study
Proton Pump Inhibitors
Deprescribing
Inappropriate Use
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 479 (estimated)
- Sponsor
- RAK Medical and Health Sciences University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to determine if a pharmacist-led educational intervention can reduce the inappropriate use of proton pump inhibitors (PPIs) among adult patients (≥18 years) with potentially inappropriate PPI prescriptions in Ras Al Khaimah.
The main questions it aims to answer are:
* Can a pharmacist-led education program reduce unnecessary PPI use?
* Does the intervention improve pati…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Physicians will be eligible to participate if:
* They are prescribing PPIs in outpatient department of the study sites
* They have patients with potentially inappropriate PPI prescriptions
Patients will be eligible to participate if:
* They are ≥18 years
* They are presenting…
Contacts